Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies

被引:33
作者
Healy, Sara J. [1 ]
Nagaraja, Haikady N. [2 ]
Alwan, Dhuha [3 ]
Dungan, Kathleen M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, 5th Floor McCampbell Hall,1581 Dodd Dr, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA
关键词
Steroid-induced hyperglycemia; Inpatient; Hematological malignancies; ACUTE MYELOID-LEUKEMIA; DIABETES-MELLITUS; TACROLIMUS FK506; SURVIVORS; TRANSPLANTATION; MORTALITY; THERAPY; HODGKIN; DISEASE; RISK;
D O I
10.1007/s12020-016-1220-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies We performed retrospective analysis of patients who were hospitalized on any of the four hematology services or bone marrow transplant service and who received systemic steroids during a 2-month period. Mean glucoses for days 1-4 and maximum glucose were calculated and the total daily steroid dose was converted to equivalent dose of dexamethasone. Hyperglycemia was defined as any glucose > 9.917 mmol/l during days 1-4. We examined associations between variables using Spearman's correlations and multivariable linear regression 168 patients were included in the analysis. Mean age was 57.1 +/- 14.4 years with 59% males and 90% Caucasians. The prevalence of hyperglycemia was 39%. Eight patients received intravenous insulin. In patients without diabetes, steroid dose equivalent to > 12 mg dexamethasone and longer acting steroids caused greater degree of hyperglycemia compared to a dose < 12 mg. Maximum glucose was a predictor of hospital length of stay among patients without diabetes (but not those with diabetes), and with acute leukemia or stem cell transplant (but not other hematologic malignancies). There were no significant differences in in mortality or other outcomes between the groups with and without hyperglycemia Hyperglycemia is common in patients with hematologic malignancies, which require frequent corticosteroids. Higher steroid dose and long-acting steroids caused a greater degree of hyperglycemia. Maximum glucose was a predictor of length of stay but this was only significant for patients without diabetes, those with acute hematologic malignancy or stem cell transplant.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
[41]   Prevalence, Treatment, and Outcomes Associated With OSA Among Patients Hospitalized With Pneumonia [J].
Lindenauer, Peter K. ;
Stefan, Mihaela S. ;
Johnson, Karin G. ;
Priya, Aruna ;
Pekow, Penelope S. ;
Rothberg, Michael B. .
CHEST, 2014, 145 (05) :1032-1038
[42]   Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-19 [J].
Chauhan, Kinsuk ;
Pattharanitima, Pattharawin ;
Piani, Federica ;
Johnson, Richard J. ;
Uribarri, Jaime ;
Chan, Lili ;
Coca, Steven G. .
AMERICAN JOURNAL OF NEPHROLOGY, 2022, 53 (01) :78-86
[43]   Malnutrition in hospitalized patients receiving nutritionally complete menus: prevalence and outcomes [J].
Calleja Fernandez, Alicia ;
Vidal Casariego, Alfonso ;
Cano Rodriguez, Isidoro ;
Ballesteros Pomar, Maria D. .
NUTRICION HOSPITALARIA, 2014, 30 (06) :1344-1349
[44]   The Impact of Reported Beta-Lactam Allergy in Hospitalized Patients With Hematologic Malignancies Requiring Antibiotics [J].
Huang, Kuan-Hsiang Gary ;
Cluzet, Valerie ;
Hamilton, Keith ;
Fadugba, Olajumoke .
CLINICAL INFECTIOUS DISEASES, 2018, 67 (01) :27-33
[45]   Are We Identifying Malnutrition in Hospitalized Patients with Hematologic Malignancies? Results from a Quality Clinical Audit [J].
Kanioura, Eftychia ;
Tzanninis, Ioannis-Georgios ;
Poulia, Kalliopi-Anna ;
Stamou, Aliki ;
Liaskas, Athanasios ;
Politis, Dimitrios ;
Kaoura, Athina ;
Garefalakis, Georgios ;
Viniou, Nora Athina ;
Diamantopoulos, Panagiotis .
DISEASES, 2022, 10 (03)
[46]   Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation [J].
Upadhyay, Jagriti ;
Trivedi, Nitin ;
Lal, Amos .
LUNG, 2020, 198 (03) :525-533
[47]   Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies [J].
Brunner, Andrew M. ;
Kim, Haesook T. ;
Coughlin, Erin ;
Alyea, Edwin P., III ;
Armand, Philippe ;
Ballen, Karen K. ;
Cutler, Corey ;
Dey, Bimalangshu R. ;
Glotzbecker, Brett ;
Koreth, John ;
McAfee, Steven L. ;
Spitzer, Thomas R. ;
Soiffer, Robert J. ;
Antin, Joseph H. ;
Ho, Vincent T. ;
Chen, Yi-Bin .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (09) :1374-1380
[48]   Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit [J].
Pastores, Stephen M. ;
Goldman, Debra A. ;
Shaz, David J. ;
Kostelecky, Natalie ;
Daley, Ryan J. ;
Peterson, Tim J. ;
Tan, Kay See ;
Halpern, Neil A. .
CANCER, 2018, 124 (14) :3025-3036
[49]   Outcomes of Specialty Palliative Care Interventions for Patients With Hematologic Malignancies: A Systematic Review [J].
Elliott, Elizabeth ;
Watson, Tracie ;
Singh, Daulath ;
Wong, Connie ;
Lo, Shelly S. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 62 (04) :863-875
[50]   Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomes [J].
Park, Jae Yoon ;
Guoa, Wei ;
Al-Hijji, Mohammed ;
El Sabbagh, Abdallah ;
Begna, Kebede H. ;
Habermann, Thomas M. ;
Witzig, Thomas E. ;
Lewis, Bradley R. ;
Lerman, Amir ;
Herrmann, Joerg .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 :6-12